Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride affects prostate development differently in male and female Mongolian gerbils.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Topical antiandrogens might be a good option for male-pattern baldness with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Castration significantly reduces prostate size and BPH symptoms.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Homeopathy can effectively treat pattern hair loss by using remedies like Lycopodium Clavatum and Natrum Muriaticum, tailored to the patient's overall condition.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

New treatments for common hair loss might be safer and more effective than current options.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.